Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxegol for Opioid-Induced Constipation in Cancer Patients
NCT02745353Phase 2Terminated
- Start
- May 2016
- Primary completion
- Jun 2017
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of naloxegol in opioid-induced constipation (OIC). Started May 2016; status: terminated.
02
Drugs
naloxegol
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT02745353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02745353.